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ABSTRACT: Obsessive-Compulsive disorder (OCD) is a 
common psychiatric condition that leads to significant impairment 
in everyday life. Advancements in neurobiological investigations 
contributed to a better understanding of pathophysiological 
mechanisms behind OCD, leading to the understanding that 
current models employed to conceptualize OCD are not 
adequate and might be a significant factor in precluding further 
advancements in how OCD is treated. In this paper, we will use 
INTRODUCTION 
Obsessive-compulsive disorder (OCD) is a psychiatric condition characterized by 
recurrent, intrusive thoughts (obsessions) and/or repetitive, 
ritualized behaviors and/or mental acts (compulsions)1. 
OCD typically starts at a young age; among boys, 
whereas among girls, the disorder usually onsets during 
early adulthood. OCD is considered a chronic condition 
throughout the lifespan2; although individuals usually 
experience periods of improvement and worsening of their 
symptomatology, hardly ever will an individual be free of 
their obsessive-compulsive symptoms (OCS)3. In that way, 
OCD can lead to significant impairment in quality of life, 
disability and indirect financial costs4.
Selective serotonin reuptake inhibitors (SSRI) 
and cognitive-behavioral therapy (CBT) are both first-
line treatments for OCD5. The latter, including a specific 
technique called exposure and response prevention (ERP), 
is the psychological treatment of choice for OCD. ERP 
involves gradual and prolonged exposure to fear-provoking 
stimuli combined with instructions to abstain from the 
compulsive behavior. Yet, despite the acute efficacy of 
SSRIs and ERP in the treatment of OCD, some issues 
have to be considered: there are few adequately trained 
therapists able to provide ERP to every individual with 
OCD, particularly when a vast country such as Brazil is 
taken into account; SSRIs not rarely are accompanied 
by important side effects such as sexual dysfunction 
which might preclude its use, particularly among young 
individuals6. Further research looking for novel, cheaper 
interventions for OCD are required. In that way, non-
invasive neuromodulation techniques involving direct 
current stimulation - transcranial direct current stimulation 
(tDCS) or transcranial magnetic stimulation- could provide 
a circuit-based treatment (i.e. targeting specific neural 
circuits) with fewer side effects. In fact, a recent clinical 
trial showed that TMS can be used for the treatment of 
OCD7. tDCS, which is cheaper than TMS, can also be 
applied at home, which would facilitate its use across a large 
population. Case reports and case series testing the efficacy 
of tDCS for OCD have reported promising findings8. Two 
recent controlled trials suggested the efficacy of tDCS 
for the treatment of OCD. In both studies, the target of 
OCD as a model to discuss the limitations of the current diagnostic 
systems in Psychiatry and to present the novel perspectives based 
on neurobiological findings that might lead to considerable 
advancements in treatments for OCD.
Keywords: Obsessive-compulsive disorder/diagnosis; Obsessive-
compulsive disorder/physiopathology; Obsessive-compulsive 
disorder/therapy; Neurobiology/trends.
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the intervention was the pre-supplementary motor area 
(SMA)9,10. Further research is required to replicate these 
initial findings.
Dimensional model of OCD
OCD is a highly heterogeneous psychiatric 
condition as two individuals with the same diagnosis can 
present with very distinct, non-overlapping profiles of 
obsession and/or compulsions. For instance, someone with 
OCD might wash their hands multiple times a day due to 
preoccupation with getting sick or spreading an illness; 
constantly pray or apologize to God due to an excessive 
concern with “right vs. wrong”; repeat the same sentence 
over and over again with some neutralizing though to 
ease the distress caused by intrusive, unwanted violent or 
sexual images (e.g. “I am not a violent person”). Previous 
research acknowledged the heterogeneity of OCS by 
analyzing the different factors (i.e. unobserved variables 
that might explain the variations of observed variables) of 
the Yale-Brown Obsessive-Compulsive Scale (YBOCS) 
through factor analysis studies. A meta-analysis of such 
studies demonstrated the clinical heterogeneity typically 
seen in OCS could be explained by four factors, which 
were labeled the four dimensions of OCS; specifically, the 
four OCS dimensions reported by the meta-analysis were 
(1) contamination/washing, (2) symmetry/ordering, (3) 
forbidden thoughts/ checking and (4) hoarding11-13.
Given OCD is clinically heterogeneous, researchers 
got interested into evaluating whether the clinical 
heterogeneity of OCS could explain the inconsistent 
findings regarding neurobiological substrates of OCD. 
Specifically, considering the clinical heterogeneity of 
OCD, researchers were interested into evaluating whether 
different OCS dimensions were associated with different 
neurobiological mechanisms and whether a specific 
neurobiological substrate could be associated with each 
OCS dimension. In that way, Mataix-Cols et al.14 employed 
functional magnetic resonance imaging (fMRI) to evaluate 
which brain regions would be most activate in sixteen 
patients with OCD when visual stimuli from different 
OCS dimensions were presented. Interestingly, authors 
reported that different OCS dimensions were related to 
relatively distinct components of the frontostriatothalamic 
circuits. For instance, when facing contamination/washing-
related stimuli, patients demonstrated a significantly 
greater activation than controls in bilateral ventromedial 
prefrontal regions and right caudate nucleus, whereas 
when facing forbidden thoughts/checking stimuli, patients 
demonstrated a significantly greater activation than 
controls in the putamen/globus pallidus, thalamus and 
dorsal cortical areas. Similar OCS-related differences 
were reported by van den Heuvel et al.15 who, instead of 
looking at activation of brain areas through fMRI, aimed 
at looking at differences in the volumes of grey matter and 
white matter of different brain regions and concluded that 
individuals with symptoms of the symmetry dimension 
were associated with decreased volume of the right motor 
cortex. Similarly, Alvarenga et al.16 reported that while 
individuals with higher scores on the aggression dimension 
had greater volumes in the lateral parietal cortex in both 
hemispheres, individuals who scored higher in the sexual/
religious dimension had a greater volumes in the insula in 
both hemispheres.
Researchers were also interested into evaluating 
whether different OCS dimensions were associated with 
different patterns of response to treatment. For instance, 
it could be possible that individuals with symptoms of the 
forbidden thoughts/checking dimension would respond 
better to usual psychotherapeutic approaches typically 
employed for OCD. In that way, Mataix-Cols et al.39 
analyzed data from 153 patients with OCD who had 
participated in a multi-center randomized controlled trial of 
computer - versus clinician-guided behavioral therapy for 
OCD and reported that individuals with forbidden thoughts/
checking and contamination/cleaning symptoms responded 
better to the intervention than individuals who did not 
present with such symptoms. Ferrao et al.17 reported that 
individuals who had higher scores in the forbidden thoughts 
dimension were more likely to not respond to conventional, 
first-line treatments of OCD (SSRIs and ERP). 
Limitations of the dimensional approach to OCD
The dimensional model of OCD is arguably the 
most studied model of OCD. Yet, despite its importance, 
this model clearly has important limitations that should 
be considered. The dimensional model was constructed 
through phenotypic data, i.e. reports of symptoms from 
individuals living with OCD. Although the reported 
symptomatology is of paramount importance in Psychiatry, 
classifying individuals according only to their symptoms 
can be misleading. In Medicine, there are several different 
examples of syndromes in which, although the symptoms 
and the clinical presentation are fairly similar, the 
underlying mechanism between different etiologies as well 
as their treatment is considerably different. For example, if 
we consider a sexually active woman in their reproductive 
years who presents to the Emergency Department with a 
strong, sharp pain in the right lower abdomen, physicians 
should suspect of either an Appendicitis or a ruptured 
tubal ectopic pregnancy; in this case, both diseases are 
characterized by different mechanisms (gastro-intestinal 
inflammation vs. embryo attachment in the tube) and require 
different treatments (appendicectomy vs. salpingectomy). 
Therefore, it could be possible that, although individuals 
with OCD might report somewhat similar symptoms if we 
consider OCS dimensions individually, there are different 
mechanisms underlying OCS symptomatology. This 
hypothesis is reinforced by the fact that larger neuroimaging 
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studies employing mega-analysis techniques failed to 
demonstrate specific neuroanatomical correlates for each 
OCS dimension as well as distinct treatment response 
patterns18,19. 
The RDoC initiative and novel insights on classifying 
OCD
The relative failure in finding adequate treatment 
for psychiatric disorders in general, exemplified by the 
lack of consistent findings regarding the model using OCS 
dimensions lead to new initiatives focused in understanding 
the mechanisms underlying OCD with the hope that this 
approach could lead to significant improvements in how we 
currently treat this condition. In fact, the National Institute 
of Mental Health (NIMH) launched in the beginning of this 
decade the Research Domain Criteria (RDoC) initiative 
with the intent of fostering research aimed at understanding 
further the neurobiological processes underlying mental 
phenomena. Currently, the NIMH does not provide funding 
to intervention trials that do not test the mechanism 
of action of the proposed treatment. In other words, to 
get NIMH funding, researchers in the U.S. carrying 
out a trial of intranasal ketamine for acute suicidality 
in adults have necessarily to include in their protocol 
a plan to collect biomarker data (e.g. neuroimaging, 
electroencephalographic measures, serum markers, etc.).
The RDoC initiative is not directly related to the 
American Psychiatric Association (APA) and its Diagnostic 
and Statistical Manual of Mental Disorders (DSM), 
currently on its fifth edition; therefore, the RDoC initiative 
does not consider the existence of mental disorders as they 
were classified by the DSM. In fact, the overall concept 
behind RDoC is to delineate different psychological 
constructs or domains of psychopathology which would be 
associated with specific neurobiological correlates and that 
would be important to normal psychological functioning. 
For instance, the construct affiliation and attachment 
underlies the processes of engagement in positive social 
interactions with other individuals, the construct arousal 
underlies the continuum of sensitivity of the organism to 
internal and/or external stimuli which facilitates interaction 
with the environment in a context-specific manner and the 
construct reward anticipation underlies processes that are 
associated with the ability to anticipate and/or represent a 
future incentive.
Although the RDoC initiative does not consider the 
categories of mental disorders determined by the DSM, 
researchers specialized in different psychiatric disorders 
advocate that the constructs from the RDoC initiative 
might provide a novel and interesting perspective in the 
understanding of mental disorders. Particularly, researchers 
are increasingly interested in providing neurobiological 
explanations to clinical characteristics of diagnostic 
categories by considering psychiatric symptoms as 
disturbances in the normal functioning of RDoC constructs. 
For example, Brotman et al.20 provides a magnificent 
example of such approach in which authors conceptualize 
the behavioral symptom of irritability as dysfunctions in 
the reward or threat processing systems - both of which are 
RDoC constructs. Although approaches such as this are yet 
largely theoretical, researchers view with optimism that our 
understanding of the neurobiology underlying psychiatric 
disorders will improve with the RDoC initiative.
RDoC constructs and OCD: sensory phenomena as an 
example
At the moment, few researchers have looked at what 
RDoC constructs might be important for our understanding 
of OCD. The few available reports at the moment have 
mostly focused on inhibitory control and fear/anxiety. This 
is mostly because initial theories about OCD considered 
that individuals would repeat a given behavior due to the 
inability to suppress engaging in the behavior once faced 
with fear and/or anxiety provoked by obsessions. Little 
attention has been given to other possible constructs 
that could play an important role in OCD, such as the 
sensorimotor/interoceptive system.
Although the hallmark clinical features of OCD 
are the obsessions and compulsions, some individuals 
with OCD also acknowledge experiencing unpleasant, 
distressing sensory experiences which have been described 
under the term sensory phenomena21-23. Among such 
distressing experiences, individuals report experimenting 
urges which can be localized to specific body regions as 
well as sensations that “something is just not right”. Sensory 
phenomena cut across different psychiatric disorders, as 
those with Tourette’s syndrome (TS), trichotillomania 
and addictive disorders also report experiencing sensory 
phenomena.
One of the earliest descriptions of sensory 
phenomena and possibly the first to systematically assess 
such symptoms in articles published in scientific journals 
were made during the 1990s. Leckman et al.24 showed that 
about 93% of individuals with Tourette Syndrome (ST) of 
the Tourette Association of America (Tourette Association 
of America) who participated in a mail interview reported 
experiencing tension sensations or urges that were 
momentarily relieved by the occurrence of tics; 89% of 
individuals with TS who reported experiencing these 
sensory experiences, at that time called premonitory urges, 
considered these sensations as physical characteristics often 
related to a body segment such as head, neck and shoulders. 
After a year, Leckman et al.25 also reported that among 
those with TS, those with OCD as a comorbidity reported 
more frequently needing to repeat behavior because they 
felt a nonspecific feeling of incompleteness or something 
“not just right”; these “not just right” sensations were 
considered mental phenomena by about 95% of individuals 
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who reported experiencing them.
Miguel et al.22 compared patients with OCD, ST, 
and OCD with comorbid ST to assess differences in the 
presence of these subjective sensations antecedent to the 
occurrence of repeated behaviors; authors reported results 
showed that patients with OCD also had both “not just 
right” sensations and physical sensations located in body 
segments, with both types of sensory experiences being 
more common in patients with OCD who presented TS 
as comorbidity21. In order to develop an instrument for 
the evaluation of sensorial phenomena in OCD patients, 
Rosário et al.23 developed the Sensory Phenomena Scale 
of the University of São Paulo (University of São Paulo 
Sensory Phenomena Scale, USP-SPS); in this instrument, 
sensations of “not just right” and physical sensations were 
grouped into a single quantitative measure that provides 
an estimate of the severity of sensory phenomena as a 
whole. Much of the research on sensory phenomena in 
OCD that followed used USP-SPS as a measure of sensory 
phenomena.
At the moment, there is little data regarding possible 
neurobiological correlates of sensory phenomena in OCD. 
Understanding the neurobiological correlates of such 
subjective experiences might enable the development of 
site-specific interventions targeting the neural circuits 
associated specifically with sensory phenomena in 
individuals who suffer from them. Among individuals 
with TS, behavioral and neurofunctional studies point 
to an important role of interoception in the genesis of 
sensory phenomena. Interoception refers to the ability of 
individuals to sense internal body states26 - i.e. the capability 
of sensing own body signals. Ganos et al.27 demonstrated 
that interoceptive perception is an important predictor 
of the severity of sensory phenomena measured by the 
Premonitory Urges for Tics Scale (PUTS)28 in TS patients. 
Rae et al.29 demonstrated that the severity of sensory 
phenomena in their sample of TS patients correlated 
positively with interoceptive sensitivity, but not with 
interoceptive perception - which presented a significant 
positive correlation only with tics severity measured by 
the global severity scale (Yale Global Tic Severity Scale, 
YGTSS)30. Still, several functional neuroimaging studies 
show that areas involved in interoceptive processes activate 
just before the occurrence of tics; for example, conducted 
the first study to evaluate neurofunctional correlates of 
tics and reported that, during tic occurrence, there was 
significant hyperactivation as measured by positron 
emission tomography, insula, somatosensory cortex, and 
SMA. Bohlhalter et al.31, Neuner et al.32 and Wang et al.33 
reported similar results when analyzing the activation of 
different brain areas through functional magnetic resonance 
imaging; particularly, SMA and somatosensory cortex 
appear to be activated prior to the occurrence of tics, 
whereas insula and other paralimbic areas (eg ACC) appear 
to be activated for about 1s prior to the occurrence of tics.
Studies investigating the relationship between 
interoception and sensory phenomena in OCD are largely 
lacking. Subira et al.34 demonstrated that patients with OCD 
who reported experiencing sensory phenomena had a higher 
volume of somatosensory cortex than patients with OCD 
who did not report sensory phenomena. Recently, Brown 
et al.35 demonstrated a significant correlation between the 
severity of sensory phenomena measured by the USP-
SPS scale and the hyperactivation of insula measured by 
functional magnetic resonance versus stimuli considered 
interoceptive in patients with OCD; however, the authors 
failed to demonstrate a significant correlation between 
scores of the multidimensional assessment of interoceptive 
perception (MAIA)36, a measure of interoceptive sensitivity, 
and severity of sensory phenomena. Different factors may 
explain this negative result. For example, it is possible that 
the measure of interoceptive sensitivity is not adequate to 
evaluate interoceptive ability because it does not consider 
an objective measure of interoception, that is, the actual 
interoceptive performance of the study participants. 
Moreover, it is also possible that the negative results arise 
from the fact that the authors did not consider possible 
heterogeneity of neurobiological correlates associated with 
mental sensorial phenomena vs. body sensorial phenomena.
Therefore, future research on OCD could aim at 
demonstrating the neurobiological correlates of sensory 
phenomena; particularly, it would be interesting to look 
at whether brain regions associated with interoceptive 
processing are also associated with the genesis of sensory 
phenomena in OCD. In that way, researchers could further 
develop circuit-specific interventions that could lead 
to better outcomes than the ones obtained with current 
treatments available for OCD. Although these developing 
interventions targeted at specific neural circuits is 
somewhat novel in Psychiatry, few researchers have already 
tried to evaluate the efficacy of novel interventions for OCD 
considering the proposed pathophysiological pathways. 
For instance, considering the possible relationship 
between sensory phenomena and interoception, Stern et 
al.37 recently demonstrated that high-dose ondansetron 
is capable of reducing the activation of brain regions 
involved in interoception, such as the insula; it remains 
to be seen whether ondansetron can be effective in the 
treatment of OCD, particularly among those individuals 
who experience sensory phenomena and are likely to have 
disturbances in the interoceptive system. A randomized, 
controlled trial previously employed ondansetron as an 
augmentation strategy in the treatment of individuals 
with OCD who did not respond to initial treatments, with 
promising results reported38. Additionally, da Silva et al.* 
(unpublished) recently carried out a clinical trial evaluating 
*Personal comunication - Silva et al.
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the effectiveness of brain stimulation through direct current 
on the supplementary motor area as a treatment for OCD, 
with promising results found; it remains to be seen whether 
such circuit-based treatment approach could be effective 
in individuals with OCD who report sensory phenomena.
In conclusion, Psychiatry, in line with other 
specialties in Medicine, is a science in continuous 
transformation. Although diagnostic criteria as established 
by the ICD and the DSM are key to clinical practice and 
uniformization of diagnosis, treatment and research, 
they do not consider neurobiological information. 
Physiopathological information about mental disorders 
could be employed to improve treatment of individuals 
with psychiatric disorders; yet, it is not clear how this 
could be done. Elucidating the participation of specific 
brain circuitries involved in transdiagnostic features of 
mental disorders is potentially of great clinical value to 
guide neurocircuitry-based treatments based on the RDoC 
initiative. The RDoC approach is novel and there are few 
studies evaluating how their domains can translate into 
clinical practice to generate diagnostic and treatment 
benefits in comparison to current categorial models. 
Future workgroups of diagnostic manuals should likely 
consider establishing experimental diagnostic criteria 
which considers neurobiological data in addition to 
common diagnostic criteria to expand further research on 
Psychiatry. Initiatives aimed at identifying intermediate 
transdiagnostic phenotypes among different psychiatric 
disorders are also promising and can lead to significant 
advancements in the field.
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